Literature DB >> 17599977

Reducing the length of time between HIV infection and diagnosis.

Catherine Dodds, Peter Weatherburn.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17599977      PMCID： PMC1906616          DOI： 10.1136/bmj.39245.570093.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Uptake of HIV screening in genitourinary medicine after change to "opt-out" consent.

Authors:  Belinda Stanley; Jane Fraser; N H Cox
Journal:  BMJ       Date:  2003-05-31

2.  New strategies for increasing the detection of HIV: analysis of routine data.

Authors:  James Read; S J Winceslaus
Journal:  BMJ       Date:  2003-05-17

3.  Monitoring the uptake of HIV testing among first attendees at GUM clinics in the East of England region.

Authors:  I Abubakar; S Bracebridge; L Willocks
Journal:  Commun Dis Public Health       Date:  2004-09

Review 4.  UK National Guidelines on HIV Testing 2006.

Authors:  K Rogstad; A Palfreeman; G Rooney; G J Hart; R Lowbury; P Mortimer; P Carter; S Jarrett; E Stewart; J Summerside
Journal:  Int J STD AIDS       Date:  2006-10       Impact factor: 1.359

Review 5.  Routine testing to reduce late HIV diagnosis in France.

Authors:  Cyrille Delpierre; Lise Cuzin; France Lert
Journal:  BMJ       Date:  2007-06-30

Review 6.  Time to move towards opt-out testing for HIV in the UK.

Authors:  M Hamill; K Burgoine; F Farrell; J Hemelaar; G Patel; D E Welchew; H W Jaffe
Journal:  BMJ       Date:  2007-06-30

7.  Criminal prosecutions for HIV transmission: people living with HIV respond.

Authors:  C Dodds; P Keogh
Journal:  Int J STD AIDS       Date:  2006-05       Impact factor: 1.359

8.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

9.  Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group.

Authors:  M L Kamb; M Fishbein; J M Douglas; F Rhodes; J Rogers; G Bolan; J Zenilman; T Hoxworth; C K Malotte; M Iatesta; C Kent; A Lentz; S Graziano; R H Byers; T A Peterman
Journal:  JAMA       Date:  1998-10-07       Impact factor: 56.272

10.  Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.

Authors:  David R Holtgrave
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069
  10 in total
  4 in total

1.  A patient carrying HIV.

Authors:  Bashir Adeela
Journal:  BMJ Case Rep       Date:  2009-05-17

2.  Should we implement 'opt-out' HIV testing for patients with lymphoma?

Authors:  J Cave; S G Edwards; R F Miller; K M Ardeshna; S M Lee
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

3.  Acceptability, perceived reliability and challenges associated with distributing HIV self-test kits to young MSM in Uganda: a qualitative study.

Authors:  Stephen Okoboi; Adelline Twimukye; Oucul Lazarus; Barbara Castelnuovo; Collins Agaba; Muloni Immaculate; Mastula Nanfuka; Andrew Kambugu; Rachel King
Journal:  J Int AIDS Soc       Date:  2019-03       Impact factor: 5.396

4.  HIV Self-Testing among Men Who Have Sex with Men (MSM) in the UK: A Qualitative Study of Barriers and Facilitators, Intervention Preferences and Perceived Impacts.

Authors:  T Charles Witzel; Alison J Rodger; Fiona M Burns; Tim Rhodes; Peter Weatherburn
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.